Healthcare, as a basic human right, has often become the focus of the development of
innovative technologies. Technological progress has significantly contributed to the …

The blood–brain barrier (BBB) is a vital boundary between neural tissue and circulating
blood. The BBB's unique and protective features control brain homeostasis as well as ion …

Peptide–and protein–nanoparticle conjugates have emerged as powerful tools for
biomedical applications, enabling the treatment, diagnosis, and prevention of disease. In …

Recent advances in technology are expected to increase our current understanding of
neuroscience. Nanotechnology and nanomaterials can alter and control neural functionality …

Gold nanoparticles (AuNPs) have been extensively used as nanomaterials for theranostic
applications due to their multifunctional characteristics in therapeutics, imaging, and surface …

Central nervous system diseases are a heavy burden on society and health care systems.
Hence, the delivery of drugs to the brain has gained more and more interest. The brain is …

Peptide–nanoparticle conjugates (PNCs) have recently emerged as a versatile tool for
biomedical applications. Synergism between the two promising classes of materials allows …

Dementia is caused by factors that damage neurons. We quantified small molecular markers
in whole blood of dementia patients, using nontargeted liquid chromatography–mass …

Nanotechnology provides a flexible platform for the development of effective therapeutic
nanomaterials that can interact specifically with a target in a biological system and provoke a …

The treatment of Alzheimer's disease and many other brain-related disorders is limited
because of the presence of the blood–brain barrier, which highly regulate the crossing of …